As of 2025-09-17, the Relative Valuation of Fortress Biotech Inc (FBIO) is (13.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.43 USD, the upside of Fortress Biotech Inc based on Relative Valuation is -491.4%.
The range of the Relative Valuation is (11.39) - (13.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 20.5x | 18.0x |
| Forward P/E multiples | 16.8x - 26.4x | 21.6x |
| Fair Price | (11.39) - (13.91) | (13.43) |
| Upside | -432.1% - -505.7% | -491.4% |
| Date | P/E |
| 2025-09-11 | -5.65 |
| 2025-09-10 | -5.69 |
| 2025-09-09 | -5.29 |
| 2025-09-08 | -5.31 |
| 2025-09-05 | -5.47 |
| 2025-09-04 | -4.19 |
| 2025-09-03 | -4.35 |
| 2025-09-02 | -4.39 |
| 2025-08-29 | -3.80 |
| 2025-08-28 | -3.57 |
| 2025-08-27 | -3.45 |
| 2025-08-26 | -3.47 |
| 2025-08-25 | -3.38 |
| 2025-08-22 | -3.35 |
| 2025-08-21 | -3.30 |
| 2025-08-20 | -3.02 |
| 2025-08-19 | -3.23 |
| 2025-08-18 | -3.32 |
| 2025-08-15 | -3.13 |
| 2025-08-14 | -2.89 |
| 2025-08-13 | -2.85 |
| 2025-08-12 | -2.96 |
| 2025-08-11 | -2.83 |
| 2025-08-08 | -2.68 |
| 2025-08-07 | -2.73 |
| 2025-08-06 | -2.77 |
| 2025-08-05 | -2.81 |
| 2025-08-04 | -2.77 |
| 2025-08-01 | -2.67 |
| 2025-07-31 | -2.73 |
| 2025-07-30 | -2.71 |
| 2025-07-29 | -2.79 |
| 2025-07-28 | -2.92 |
| 2025-07-25 | -2.91 |
| 2025-07-24 | -2.86 |
| 2025-07-23 | -2.85 |
| 2025-07-22 | -2.91 |
| 2025-07-21 | -2.79 |
| 2025-07-18 | -2.88 |
| 2025-07-17 | -2.85 |
| 2025-07-16 | -2.91 |
| 2025-07-15 | -2.86 |
| 2025-07-14 | -2.89 |
| 2025-07-11 | -2.79 |
| 2025-07-10 | -2.93 |
| 2025-07-09 | -2.93 |
| 2025-07-08 | -2.85 |
| 2025-07-07 | -2.82 |
| 2025-07-03 | -2.77 |
| 2025-07-02 | -2.70 |